Voyager Therapeutics, Inc. (66)
Browse by Contract Category
Contracts
-
Consulting Agreement, by and between the Registrant and Robert W. Hesslein, dated April 28, 2023
(Filed With SEC on May 9, 2023)
-
Amended and Restated Investor Agreement by and between the Registrant and Neurocrine Biosciences, Inc., dated as of January 8, 2023
(Filed With SEC on March 7, 2023)
-
Collaboration and License Agreement by and between the Registrant and Neurocrine Biosciences, Inc., dated as of January 8, 2023
(Filed With SEC on March 7, 2023)
-
Stock Purchase Agreement by and between the Registrant and Neurocrine Biosciences, Inc., dated as of January 8, 2023
(Filed With SEC on March 7, 2023)
-
Patent and Know-How Licence between the Registrant and Touchlight IP Limited, dated as of November 3, 2022
(Filed With SEC on March 7, 2023)
-
Option and License Agreement by and between the Registrant and Novartis Pharma AG, dated March 4, 2022
(Filed With SEC on March 7, 2023)
-
Transition, Separation and Release of Claims Agreement, by and between the Company and Robert W. Hesslein, dated February 22, 2023
(Filed With SEC on February 23, 2023)
-
Employment Agreement, by and between Voyager Therapeutics, Inc. and Todd Carter, Ph.D., effective as of September 7, 2022
(Filed With SEC on September 7, 2022)
-
Employment Agreement, by and between Voyager Therapeutics, Inc. and Peter Pfreundschuh, effective as of September 7, 2022
(Filed With SEC on September 7, 2022)
-
Sublease Termination Agreement by and between Voyager Therapeutics, Inc. and BioNTech US Inc., dated as of June 22, 2022
(Filed With SEC on June 23, 2022)
-
Lease Termination Agreement by and between Voyager Therapeutics, Inc. and BRE-BMR Pilgrim & Sidney LLC, dated as of June 22, 2022
(Filed With SEC on June 23, 2022)
-
Consulting Agreement by and between Voyager Therapeutics, Inc. and Glenn Pierce, M.D., Ph.D., effective as of June 6, 2022
(Filed With SEC on June 7, 2022)
-
Option and License Agreement by and between the Registrant and Novartis Pharma AG, dated March 4, 2022
(Filed With SEC on May 4, 2022)
-
Employment Agreement, by and between Voyager Therapeutics, Inc. and Alfred Sandrock, M.D., Ph.D., effective as of March 22, 2022
(Filed With SEC on March 22, 2022)
-
Separation and Release of Claims Agreement by and between the Registrant and Allison Dorval, effective December 13, 2021
(Filed With SEC on March 8, 2022)
-
Consulting Agreement by and between the Registrant and Allison Dorval, dated as of November 26, 2021
(Filed With SEC on March 8, 2022)
-
Employment Agreement, by and between the Registrant and Julie Burek, dated as of October 1, 2021
(Filed With SEC on March 8, 2022)
-
Consulting Agreement by and between Voyager Therapeutics, Inc. and Alfred Sandrock, effective as of February 7, 2022
(Filed With SEC on February 3, 2022)
-
Amended and Restated Employment Agreement, by and between Voyager Therapeutics, Inc. and Robin Swartz, effective as of February 7, 2022
(Filed With SEC on February 3, 2022)
-
Sublease Agreement, by and between Registrant and BioNTech US Inc., dated September 3, 2021
(Filed With SEC on November 2, 2021)
-
Option and License Agreement, by and between the Registrant and Pfizer Inc., dated October 1, 2021
(Filed With SEC on November 2, 2021)
-
Amendment No. 1 to Employment Agreement, by and between the Registrant and Glenn Pierce, dated June 7, 2021
(Filed With SEC on June 8, 2021)
-
Transition, Separation and Release of Claims Agreement, by and between the Registrant and G. Andre Turenne, dated May 19, 2021
(Filed With SEC on May 19, 2021)
-
Employment Agreement, by and between the Registrant and Michael Higgins, dated May 19, 2021
(Filed With SEC on May 19, 2021)
-
Employment Agreement, by and between the Registrant and Glenn Pierce, M.D., Ph.D., dated May 19, 2021
(Filed With SEC on May 19, 2021)
-
AMENDMENT NO. 2 TO CONSULTING AGREEMENT
(Filed With SEC on February 25, 2021)
-
First Amendment to Amended and Restated Option and License Agreement with Genzyme Corporation, dated September 20, 2020
(Filed With SEC on November 9, 2020)
-
Lease Agreement, by and between the Registrant and HCP/King 75 Hayden LLC, dated March 16, 2020
(Filed With SEC on March 19, 2020)
-
Description of Registrants Securities
(Filed With SEC on March 3, 2020)
-
Transition, Separation, and Release of Claims Agreement, by and between the Company and Matthew P. Ottmer, dated as of February 12, 2020
(Filed With SEC on February 14, 2020)
-
Amendment No. 1 to Consulting Agreement, by and between the Corporation and Steven M. Paul, M.D., dated July 9, 2019
(Filed With SEC on November 6, 2019)
-
Amendment No. 1 to Consulting Agreement, by and between the Corporation and Dinah Sah, dated September 16, 2019
(Filed With SEC on November 6, 2019)
-
Termination Agreement, by and between Voyager Therapeutics, Inc. and Genzyme Corporation, dated June 14, 2019
(Filed With SEC on August 9, 2019)
-
Employment Agreement, by and between Voyager Therapeutics, Inc. and Omar Khwaja, M.D., Ph.D, dated May 20, 2019
(Filed With SEC on August 9, 2019)
-
Consulting Agreement, by and between Voyager Therapeutics, Inc. and Dinah Sah, Ph.D., dated June 28, 2019
(Filed With SEC on August 9, 2019)
-
Amendment No. 1 to the Collaboration and License Agreement, by and between Voyager Therapeutics, Inc. and Neurocrine Biosciences, Inc., dated June 14, 2019
(Filed With SEC on August 9, 2019)
-
Amended and Restated Option and License Agreement, by and between Voyager Therapeutics, Inc. and Genzyme Corporation, dated June 14, 2019
(Filed With SEC on August 9, 2019)
-
Retirement Agreement, by and between the Company and Dinah Sah, dated as of May 20, 2019
(Filed With SEC on May 21, 2019)
-
Employment Agreement, by and between the Registrant and Robert W. Hesslein, dated January 15, 2019
(Filed With SEC on May 7, 2019)
-
Form of Non-Qualified Stock Option Agreement for Inducement Grant
(Filed With SEC on February 26, 2019)
-
Employment Agreement, by and between Voyager Therapeutics, Inc. and Allison Dorval, dated November 7, 2018
(Filed With SEC on November 7, 2018)
-
Non-Qualified Stock Option Agreement, by and between Voyager Therapeutics, Inc. and G. Andre Turenne, dated as of July 16, 2018
(Filed With SEC on November 7, 2018)
-
Consulting Agreement, by and between Voyager Therapeutics, Inc. and Steven M. Paul, M.D., dated August 2, 2018
(Filed With SEC on August 7, 2018)
-
Retirement Agreement, by and between Voyager Therapeutics, Inc. and Steven M. Paul, dated as of June 28, 2018
(Filed With SEC on June 29, 2018)
-
Employment Agreement, by and between Voyager Therapeutics, Inc. and G. Andre Turenne, dated as of June 28, 2018
(Filed With SEC on June 29, 2018)
-
Third Amendment to Lease Agreement, by and between Voyager Therapeutics, Inc. and UP 45/75 Sidney Street, LLC, dated June 1, 2018
(Filed With SEC on June 5, 2018)
-
First Amendment to Lease Agreement, by and between Voyager Therapeutics, Inc. and UP 64 Sidney Street, LLC, dated June 1, 2018
(Filed With SEC on June 5, 2018)
-
Amendment No. 1 to 2015 Employee Stock Purchase Plan
(Filed With SEC on March 14, 2018)
-
Specimen Common Stock Certificate of the Registrant
(Filed With SEC on March 14, 2018)
-
Second Amendment to Lease, by and between Voyager Therapeutics, Inc. and UP 45/75 Sidney Street, LLC, dated February 5, 2018
(Filed With SEC on February 7, 2018)
-
Underwriting Agreement, dated November 7, 2017, by and among Voyager Therapeutics, Inc. and Morgan Stanley & Co. LLC and Cowen and Company, LLC, as representatives of the...
(Filed With SEC on November 8, 2017)
-
Employment Agreement, effective September 11, 2017, between the Registrant and Matthew Ottmer
(Filed With SEC on September 18, 2017)
-
EMPLOYMENT AGREEMENT
(Filed With SEC on January 3, 2017)
-
EMPLOYMENT AGREEMENT
(Filed With SEC on May 12, 2016)
-
FIRST AMENDMENT TO LEASE AGREEMENT
(Filed With SEC on May 12, 2016)
-
EMPLOYMENT AGREEMENT
(Filed With SEC on May 12, 2016)
-
EMPLOYMENT AGREEMENT
(Filed With SEC on May 12, 2016)
-
EMPLOYMENT AGREEMENT
(Filed With SEC on May 12, 2016)
-
[] Voyager Therapeutics, Inc. Common Stock UNDERWRITING AGREEMENT
(Filed With SEC on October 28, 2015)
-
VOYAGER THERAPEUTICS, INC. SECOND AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT APRIL 10, 2015
(Filed With SEC on October 28, 2015)
-
VOYAGER THERAPEUTICS, INC. 2014 STOCK OPTION AND GRANT PLAN
(Filed With SEC on October 28, 2015)
-
VOYAGER THERAPEUTICS, INC. 2015 STOCK OPTION AND INCENTIVE PLAN
(Filed With SEC on October 28, 2015)
-
LEASE 45/75 Sidney Street Cambridge, Massachusetts LANDLORD UP 45/75 SIDNEY STREET, LLC TENANT VOYAGER THERAPEUTICS, INC.
(Filed With SEC on October 28, 2015)
-
VOYAGER THERAPEUTICS, INC. FORM OF DIRECTOR INDEMNIFICATION AGREEMENT
(Filed With SEC on October 28, 2015)
-
VOYAGER THERAPEUTICS, INC. FORM OF OFFICER INDEMNIFICATION AGREEMENT
(Filed With SEC on October 28, 2015)
-
VOYAGER THERAPEUTICS, INC. 2015 EMPLOYEE STOCK PURCHASE PLAN
(Filed With SEC on October 28, 2015)